Document is current

Article History

Received: 20 June 2025

Accepted: 22 July 2025

First Online: 9 August 2025

Declarations

:

: Ida Ny Frederiksen, Andreas Arnold-Vangsted, Rodrigo Anguita, Lars Christian Boberg-Ans, Lasse Jørgensen Cehofski, Elon H.C. van Dijk, Nathalie Skovgaard Eriksen, Lorenzo Ferro Desideri, Josef Huemer, Claudio Iovino, Steffen Emil Künzel, Marie Ørskov, Laurenz J. B. Pauleikhoff, and Marie Louise Roed Rasmussen declare that they have no competing interests. Jakob Grauslund declares to have received speakers fee from Allergan, Bayer, Novartis, and Roche, and to have served as an advisory board member for Allergan, Apellis, Bayer, Novartis, and Roche, not related to this work. Yousif Subhi declares to have received speakers fee from Bayer and Roche, to have served as an advisory board member for Astellas, and to be the inventor of a patent related to biomarkers for polypoidal choroidal vasculopathy (WO2020007612A1), not related to this work. Yousif Subhi is Section Editor of Ophthalmology and Therapy. Yousif Subhi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Systematic reviews, meta-analyses, and forecasting studies using publicly available data do not require institutional review board approval according to Danish law.